Department of JusticeU.S. Attorney’s OfficeDistrict of Pennsylvania FOR IMMEDIATE RELEASEThursday, April 15, 2021 HARRISBURG – The United States Attorney’s Office for the Middle District of Pennsylvania announced that Stefen Knoche, age 55, of Lebanon, Pennsylvania, was sentenced today to 70 months’ imprisonment by U.S. District Court Judge Sylvia H. Rambo for trafficking in counterfeit drugs. Knoche was…
Lake Champlain Chocolates Voluntarily Recalls Mr. Goodtime Bunny With Best By Date 11/20/2021 for Undeclared Almonds
Summary Company Announcement Date: April 15, 2021 FDA Publish Date: April 15, 2021 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Undeclared almonds Company Name: Lake Champlain Chocolates Brand Name: Brand Name(s) Mr. Goodtime Bunny Product Description: Product Description Chocolate candy Company Announcement Lake Champlain Chocolates (LCC) is issuing a public alert…
Jose Madrid Salsa Issues a Voluntary Recall Due to an Undeclared Anchovy Allergen
Summary Company Announcement Date: April 14, 2021 FDA Publish Date: April 15, 2021 Product Type: Food & Beverages Gravy/Sauces Allergens Reason for Announcement: Recall Reason Description Undeclared anchovy Company Name: Jose Madrid Salsa Brand Name: Brand Name(s) Jose Madrid Salsa Product Description: Product Description Strawberry Mild Salsa Company Announcement Jose Madrid Salsa in Zanesville, Ohio…
Blount Fine Foods Voluntarily Recalls a Limited Amount (a Single Lot) of Lobster Bisque Due to Possible Undeclared Egg Allergen
Summary Company Announcement Date: April 14, 2021 FDA Publish Date: April 15, 2021 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Undeclared egg Company Name: Blount Fine Foods Brand Name: Brand Name(s) Product Description: Product Description Lobster Bisque Company Announcement Blount Fine Foods announced that, in partnership with the FDA, it is…
FDA D.I.S.C.O. Burst Edition: Yescarta (axicabtagene ciloleucel) for adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll provide another quick update on a recent FDA cancer therapeutic approval. On March 5, 2021, the FDA granted approval to axicabtagene…
Urgent: Torn & Glasser Recalls Dark Chocolate Espresso Beans Because of Undeclared Walnut Allergen
Summary Company Announcement Date: April 13, 2021 FDA Publish Date: April 13, 2021 Product Type: Food & Beverages Reason for Announcement: Recall Reason Description Undeclared walnuts Company Name: Torn & Glasser Brand Name: Brand Name(s) Torn & Glasser Product Description: Product Description Dark chocolate espresso beans Company Announcement Torn & Glasser of Los Angeles, CA…
Snak King Corporation Issues Allergy Alert on Undeclared Milk Allergen in Trader Joe’s Restaurant Style White Corn Tortilla Chips
Summary Company Announcement Date: April 13, 2021 FDA Publish Date: April 14, 2021 Product Type: Food & Beverages Snack Food Item Allergens Reason for Announcement: Recall Reason Description Product may contain undeclared milk Company Name: Snak King Corporation Brand Name: Brand Name(s) Trader Joe’s Product Description: Product Description Restaurant Style White Corn Tortilla Chips Company…
Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Battery Life
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Medtronic Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Models: Full List of Affected Devices below Serial Numbers:…
FDA D.I.S.C.O. Burst Edition: FDA approval of Sarclisa (isatuximab-irfc) in combination with carfilzomib and dexamethasone for adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy
Podcast Welcome back to the D.I.S.C.O., FDA’s Drug Information Soundcast in Clinical Oncology, Burst Edition, brought to you by FDA’s Division of Drug Information in partnership with FDA’s Oncology Center of Excellence. Today we’ll be providing another quick update on a recent FDA cancer drug approval. On March 31, 2021, the FDA approved isatuximab-irfc (brand…
Smisson-Cartledge Biomedical, LLC Recalls ThermaCor 1200 Disposable Sets for Risk of Patient Contact to Aluminum
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product ThermaCor 1200 Disposable Sets Disposable Set Models: PTC-1200, DNC-1200, PNC-1200 Distribution Dates: 2006 to present Devices Recalled in the U.S.: 38,786 Date Initiated by Firm: February 21,…